To enroll in Self-Instruction, visit the Products Page. If you have any questions, or if you are unsure of your enrollment status, please call the Manager, Examinations and Self-Instruction, toll-free at 888.243.3368, ext. 4336.

Participants must answer at least 12 of 15 questions correctly (80%) to earn CE credit.

Note: Exercise 994 is a special edition of the Self-Instruction Exercises and is only available to those members/nonmembers who attended the 2017 Scientific Session in Las Vegas. Those who submit the exercise, but did not attend the annual meeting, will not have their exercise processed and their payment returned.

 

AGD - Self-Instruction Exercise No. 407 - Anesthesia and Pain Management
Analgesic efficacy and safety of transdermal and oral diclofenac in postoperative pain management following dental implant placement

Self-Instruction Exercise No. 407
Member Information
Required for AGD members
Required for non-members
Are you an AGD member?
Yes    No
If Yes, please enter your AGD Number:
Full Name (First & Last):
Address:
Address 2:
City:
State/Province:
ZIP/Postal Code:
Country:
E-mail:
Promotional Code


Payment Information
I am currently enrolled in the Self-Instruction program. (If you are unsure of your enrollment status, please call 888.243.3368, ext. 4336.)
Enroll me for Self-Instruction so that I can submit this exercise. My credit card information is entered below. I understand that my card will be charged $30 if I am an AGD member and $50 if I am a non-member.
 
Card Type  
Visa          MasterCard    American Express   
Card Number  
Expiration Date    


Exercise No. 407
Subject Code: 340
Anesthesia and Pain Management

The 15 questions for this exercise are based on the article Analgesic efficacy and safety of transdermal and oral diclofenac in postoperative pain management following dental implant placement on pages 69-74. This exercise was developed by Anthony S. Carroccia, DDS, MAGD, ABGD, in association with the General Dentistry Self-Instruction committee.

Reading the article and successfully completing this exercise will enable you to:

  • understand the role of transdermal pain medications;
  • review the correlation of implant placement and postoperative pain; and
  • recall features about diclofenac.

Answers for this exercise must be received by June 30, 2018.

  1. How many subjects were included in the study?

    A. 20
    B. 40
    C. 60
    D. 80

  2. Which test was used to analyze the data?

    A. Grubbs’ outlier test
    B. Kruskal-Wallis test
    C. Mann-Whitney test
    D. paired t test

  3. The time frame of greatest postoperative pain after implant placement is _____ hours postsurgery.

    A. 1-2
    B. 3-4
    C. 5-6
    D. 7-8

  4. All of the following are proper surgical guidelines to reduce postoperative pain except one. Which is the exception?

    A. gentle tissue handling
    B. continuous drilling pressure
    C. copious osteotomy irrigation
    D. prudent suture closure

  5. All of the following are significant factors in implant postoperative pain except one. Which is the exception?

    A. older age
    B. smoking
    C. male
    D. multiple osteotomies

  6. The analgesics’ side effects of gastrointestinal bleeding and/or ulcers are shown in _____% of reports.

    A. 16
    B. 20
    C. 40
    D. 46

  7. Bypassing the _________ can greatly minimize the total drug dosage needed.

    A. first-pass metabolism
    B. second-pass metabolism
    C. distribution half-life
    D. elimination half-life

  8. Diclofenac is widely available orally and topically as a hydrophobic nonsteroidal anti-inflammatory drug. This study compared diclofenac diethylamine patches and diclofenac sodium tablets.

    A. Both statements are true.
    B. The first statement is true; the second is false.
    C. The first statement is false; the second is true.
    D. Both statements are false.

  9. Bilateral _____________ were missing from all of the test subjects.

    A. mandibular canines
    B. mandibular first molars
    C. maxillary first premolars
    D. maxillary lateral incisors

  10. The transdermal diclofenac patch was placed __________ to the surgical site.

    A. supraclavicular, ipsilateral
    B. supraclavicular, contralateral
    C. subclavian, ipsilateral
    D. subclavian, contralateral

  11. The diclofenac patch was replaced daily. Routine antibiotics were prescribed.

    A. Both statements are true.
    B. The first statement is true; the second is false.
    C. The first statement is false; the second is true.
    D. Both statements are false.

  12. All of the following are ideal characteristics for transdermal application except one. Which is the exception?

    A. long-term usage
    B. smaller dose
    C. poor bioavailability
    D. short biological half-life

  13. Patients said that the pain relief with transdermal diclofenac was adequate and comparable to pain relief with oral diclofenac. In a different study, fewer than 3.1% of patients reported cutaneous reactions with transdermal delivery of the drug.

    A. Both statements are true.
    B. The first statement is true; the second is false.
    C. The first statement is false; the second is true.
    D. Both statements are false.

  14. Transfersomes, liposomes, and ethosomes are all ways to improve drug _________.

    A. bioavailability
    B. efficacy
    C. penetration
    D. potency

  15. Heartburn or indigestion has been reported at _____% as an adverse effect of analgesics.

    A. 16
    B. 20
    C. 40
    D. 46


Evaluation

Please respond to the statements below, using the following scale:
1 Poor; 2 Below average; 3 Average; 4 Above average; 5 Excellent

Practicality of the content 1 2 3 4 5
Benefit to your clinical practice 1 2 3 4 5
Quality of illustrations 1 2 3 4 5
Clarity of objectives 1 2 3 4 5
Clarity of exercise questions 1 2 3 4 5
Relevance of exercise questions 1 2 3 4 5
 
Did this exercise achieve its objectives? Yes No
Did this article present new information? Yes No
How much time did it take you to complete this exercise? mins


Cancel